The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00667
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 19, 2019
Authors
Publisher
Frontiers Media SA